224 related articles for article (PubMed ID: 29896298)
1. Cancer radiotheranostics targeting carbonic anhydrase-IX with
Iikuni S; Ono M; Watanabe H; Shimizu Y; Sano K; Saji H
Theranostics; 2018; 8(11):2992-3006. PubMed ID: 29896298
[TBL] [Abstract][Full Text] [Related]
2. PET imaging and pharmacological therapy targeting carbonic anhydrase-IX high-expressing tumors using US2 platform based on bivalent ureidosulfonamide.
Iikuni S; Watanabe H; Shimizu Y; Nakamoto Y; Ono M
PLoS One; 2020; 15(12):e0243327. PubMed ID: 33296398
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of indium-111-labeled imidazothiadiazole sulfonamide derivative for single photon emission computed tomography imaging targeting carbonic anhydrase-IX.
Iikuni S; Okada Y; Shimizu Y; Watanabe H; Ono M
Bioorg Med Chem Lett; 2020 Jul; 30(14):127255. PubMed ID: 32527556
[TBL] [Abstract][Full Text] [Related]
4. Development of the
Iikuni S; Tanimura K; Watanabe H; Shimizu Y; Saji H; Ono M
Mol Pharm; 2019 Apr; 16(4):1489-1497. PubMed ID: 30892905
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the Pharmacokinetics of a Radioligand Targeting Carbonic Anhydrase-IX with Albumin-Binding Moieties.
Iikuni S; Okada Y; Shimizu Y; Watanabe H; Ono M
Mol Pharm; 2021 Mar; 18(3):966-975. PubMed ID: 33472371
[TBL] [Abstract][Full Text] [Related]
6. PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with (68)Ga-Labeled Benzenesulfonamides.
Lau J; Zhang Z; Jenni S; Kuo HT; Liu Z; Vullo D; Supuran CT; Lin KS; Bénard F
Mol Pharm; 2016 Mar; 13(3):1137-46. PubMed ID: 26866675
[TBL] [Abstract][Full Text] [Related]
7. A novel
Guan SS; Wu CT; Liao TZ; Lin KL; Peng CL; Shih YH; Weng MF; Chen CT; Yeh CH; Wang YC; Liu SH
Eur J Pharm Biopharm; 2021 Nov; 168():38-52. PubMed ID: 34450241
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma.
Chrastina A; Závada J; Parkkila S; Kaluz S; Kaluzová M; Rajcáni J; Pastorek J; Pastoreková S
Int J Cancer; 2003 Jul; 105(6):873-81. PubMed ID: 12767076
[TBL] [Abstract][Full Text] [Related]
9. Targeting CAIX with [
Yang X; Zhu H; Yang X; Li N; Huang H; Liu T; Guo X; Xu X; Xia L; Deng C; Tian X; Yang Z
Mol Pharm; 2019 Apr; 16(4):1532-1540. PubMed ID: 30803240
[TBL] [Abstract][Full Text] [Related]
10. Preliminary biological evaluation of ¹²⁵I-labeled anti-carbonic anhydrase IX monoclonal antibody in the mice bearing HT-29 tumors.
Li J; Shi L; Wang C; Zhang X; Jia L; Li X; Zhou W; Qi Y; Zhang L
Nucl Med Commun; 2011 Dec; 32(12):1190-3. PubMed ID: 21968435
[TBL] [Abstract][Full Text] [Related]
11. Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor.
Yang X; Minn I; Rowe SP; Banerjee SR; Gorin MA; Brummet M; Lee HS; Koo SM; Sysa-Shah P; Mease RC; Nimmagadda S; Allaf ME; Pomper MG
Oncotarget; 2015 Oct; 6(32):33733-42. PubMed ID: 26418876
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of 18F-labeled carbonic anhydrase IX inhibitors for imaging with positron emission tomography.
Pan J; Lau J; Mesak F; Hundal N; Pourghiasian M; Liu Z; Bénard F; Dedhar S; Supuran CT; Lin KS
J Enzyme Inhib Med Chem; 2014 Apr; 29(2):249-55. PubMed ID: 23463940
[TBL] [Abstract][Full Text] [Related]
13. Trimeric Radiofluorinated Sulfonamide Derivatives to Achieve In Vivo Selectivity for Carbonic Anhydrase IX-Targeted PET Imaging.
Lau J; Liu Z; Lin KS; Pan J; Zhang Z; Vullo D; Supuran CT; Perrin DM; Bénard F
J Nucl Med; 2015 Sep; 56(9):1434-40. PubMed ID: 26205302
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of novel technetium-99m-hydroxamamide complex based on imidazothiadiazole sulfonamide targeting carbonic anhydrase-IX for tumor imaging.
Iikuni S; Kitano A; Watanabe H; Shimizu Y; Ono M
Bioorg Med Chem Lett; 2020 Nov; 30(22):127596. PubMed ID: 33011287
[TBL] [Abstract][Full Text] [Related]
15. Acetazolamide-based [
More KN; Lee JY; Kim DY; Cho NC; Pyo A; Yun M; Kim HS; Kim H; Ko K; Park JH; Chang DJ
Bioorg Med Chem Lett; 2018 Mar; 28(5):915-921. PubMed ID: 29422388
[TBL] [Abstract][Full Text] [Related]
16. Two ⁹⁰Y-labeled multimeric RGD peptides RGD4 and 3PRGD2 for integrin targeted radionuclide therapy.
Liu Z; Shi J; Jia B; Yu Z; Liu Y; Zhao H; Li F; Tian J; Chen X; Liu S; Wang F
Mol Pharm; 2011 Apr; 8(2):591-9. PubMed ID: 21247151
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Nonpeptidic Ligand Conjugates for SPECT Imaging of Hypoxic and Carbonic Anhydrase IX-Expressing Cancers.
Lv PC; Putt KS; Low PS
Bioconjug Chem; 2016 Jul; 27(7):1762-9. PubMed ID: 27362480
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of the monoclonal antibody
Čepa A; Ráliš J; Král V; Paurová M; Kučka J; Humajová J; Lázníček M; Lebeda O
Appl Radiat Isot; 2018 Mar; 133():9-13. PubMed ID: 29272822
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of
Nakashima K; Iikuni S; Okada Y; Watanabe H; Shimizu Y; Nakamoto Y; Ono M
Nucl Med Biol; 2021 Feb; 93():46-53. PubMed ID: 33316738
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
